| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q1 2024 | 276 | 544,715 | QQQ, BX, AAPL, NVDA | 13F-HR | 4/11/2024 | 000108514624001722 |
| Q4 2023 | 162 | 203,379 | AAPL, NVDA, CTAS, SPY | 13F-HR | 1/10/2024 | 000108514624000193 |
| Q3 2023 | 256 | 486,844 | QQQ, BX, AAPL, EPD | RESTATEMENT | 10/13/2023 | 000108514623003719 |
| Q2 2023 | 253 | 451,664 | QQQ, BX, AAPL, EPD | 13F-HR | 7/10/2023 | 000108514623002614 |
| Q1 2023 | 142 | 286,209 | QQQ, BX, EPD, CSWC | 13F-HR | 4/7/2023 | 000108514623001555 |
| Q4 2022 | 208 | 264,134 | BX, AAPL, EPD, CSWC | 13F-HR | 1/12/2023 | 000108514623000103 |
| Q3 2022 | 293 | 408,318 | QQQ, BX, AAPL, EPD | 13F-HR | 10/7/2022 | 000108514622003285 |
| Q2 2022 | 288 | 457,091 | QQQ, BX, VYGG, AAPL | 13F-HR | 7/11/2022 | 000108514622002314 |
| Q1 2022 | 304 | 513,321 | QQQ, BX, AAPL, CSWC | 13F-HR | 4/11/2022 | 000108514622001358 |
| Q4 2021 | 336 | 578,170 | QQQ, BX, VYGG, AAPL | 13F-HR | 2/2/2022 | 000108514622000480 |
| Q3 2021 | 310 | 549,551 | QQQ, BX, VYGG, CSWC | 13F-HR | 10/12/2021 | 000108514621002733 |
| Q2 2021 | 319 | 514,712 | QQQ, BX, AAPL, VYGG | 13F-HR | 7/13/2021 | 000108514621001943 |
| Q1 2021 | 296 | 472,869 | QQQ, BX, IVV, CSWC | RESTATEMENT | 4/19/2021 | 000108514621001232 |
| Q4 2020 | 293 | 439,330 | QQQ, BX, IVV, CSWC | 13F-HR | 1/26/2021 | 000108514621000251 |
| Q3 2020 | 274 | 367,989 | QQQ, BX, ELAN, CSWC | 13F-HR | 10/16/2020 | 000108514620002543 |
| Q2 2020 | 129 | 205,526 | QQQ, BX, EPD, CSWC | 13F-HR | 7/9/2020 | 000108514620001709 |
| Q1 2020 | 191 | 102,334 | VZ, PG, TXN, QURE | RESTATEMENT | 4/10/2020 | 000108514620001081 |
| Q4 2019 | 283 | 440,337 | QQQ, CSWC, EPD, MAIN | 13F-HR | 1/9/2020 | 000108514620000051 |
| Q3 2019 | 279 | 413,130 | QQQ, CSWC, MAIN, BX | 13F-HR | 11/14/2019 | 000108514619002923 |
| Q2 2019 | 273 | 385,328 | QQQ, CSWC, MAIN, EPD | 13F-HR | 7/10/2019 | 000108514619001815 |
| Q1 2019 | 127 | 205,546 | QQQ, CSWC, EPD, MAIN | 13F-HR | 4/19/2019 | 000108514619001199 |
| Q4 2018 | 119 | 182,054 | QQQ, CSWC, EPD, MAIN | 13F-HR | 1/14/2019 | 000108514619000142 |
| Q3 2018 | 136 | 213,370 | QQQ, EPD, MAIN, JYNT | RESTATEMENT | 10/10/2018 | 000108514618002283 |
| Q2 2018 | 140 | 215,966 | EPD, MAIN, QQQ, PCG | 13F-HR | 7/10/2018 | 000108514618001660 |
| Q1 2018 | 144 | 238,714 | QQQ, JYNT, EPD, MAIN | 13F-HR | 5/14/2018 | 000108514618001385 |
| Q4 2017 | 132 | 236,687 | MAIN, EPD, XOM, QQQ | 13F-HR | 2/15/2018 | 000108514618000905 |
| Q3 2017 | 142 | 234,443 | MAIN, EPD, MR, JYNT | 13F-HR | 10/23/2017 | 000108514617002100 |
| Q2 2017 | 134 | 245,331 | MAIN, EPD, XOM, MR | 13F-HR | 7/13/2017 | 000108514617001496 |
| Q1 2017 | 146 | 273,763 | MAIN, EPD, XOM, MR | RESTATEMENT | 4/20/2017 | 000108514617001010 |
| Q4 2016 | 126 | 215,984 | MAIN, EPD, MR, TLGT | 13F-HR | 1/24/2017 | 000108514617000163 |
| Q3 2016 | 158 | 329,743 | MAIN, XOM, EPD, PDL BIOPHARMA INC | 13F-HR | 10/24/2016 | 000108514616004553 |
| Q2 2016 | 240 | 430,046 | MAIN, XOM, EPD, PDL BIOPHARMA INC | 13F-HR | 7/25/2016 | 000108514616004034 |
| Q1 2016 | 330 | 581,019 | MAIN, XOM, EPD, XLV | 13F-HR | 4/27/2016 | 000108514616003539 |